D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
Student Name
Western Governors University
D027 Advanced Pathopharmacological Foundations
Prof. Name
Date
D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
Phase 1: Timeline and Estimated Completion
| Task Description | Proposed Completion Date | Estimated Time to Complete |
|---|---|---|
| 1a. CPE schedule table | June 10, 2024 | 30 minutes |
| 1b. Feedback and Synthesis Improvement Plan | June 25, 2024 | 2 hours |
| 1b. Pathophysiology Synthesis | June 25, 2024 | 2 hours |
| 1c. Three screenshots of GoReact and reflection | June 25, 2024 | 1.5 hours |
Phase 2: Timeline and Estimated Completion
| Task Description | Proposed Completion Date | Estimated Time to Complete |
|---|---|---|
| 2a. Review CPE schedule table for progress | June 30, 2024 | 30 minutes |
| 2b. Feedback and Synthesis Improvement Plan | June 30, 2024 | 2 hours |
| 2b. Patient or Healthcare Consumer-Focused Synthesis | June 30, 2024 | 2 hours |
| 2c. Three screenshots of GoReact and reflection | June 30, 2024 | 1.5 hours |
Phase 3: Timeline and Estimated Completion
| Task Description | Proposed Completion Date | Estimated Time to Complete |
|---|---|---|
| 3a. Review CPE schedule table for progress | July 4, 2024 | 30 minutes |
| 3b. Feedback and Synthesis Improvement Plan | July 4, 2024 | 2 hours |
| 3b. Preceptor or Colleague-Focused Synthesis | July 4, 2024 | 2 hours |
| 3c. Feedback and Synthesis Improvement Plan | July 4, 2024 | 2 hours |
| 3c. Patient or Healthcare Consumer-Focused Treatment Plan | July 4, 2024 | 2 hours |
| 3d. Three screenshots of GoReact and reflection | July 4, 2024 | 2 hours |
Phase 1.1B: Advanced Professional Nurse or Colleague Pathophysiology Synthesis
What is Chronic Lower Respiratory Infection, and What Are Its Pathophysiological Mechanisms?
Chronic lower respiratory infections encompass a range of enduring lung diseases characterized by inflammation and structural damage to the lower airways. These conditions lead to persistent respiratory symptoms and diminished pulmonary function (World Health Organization [WHO], 2017). The underlying pathophysiology differs among specific diseases:
- Chronic Obstructive Pulmonary Disease (COPD): Primarily caused by prolonged inhalation of harmful substances, especially tobacco smoke, COPD involves chronic inflammation of airways, bronchitis, and alveolar destruction (emphysema).
- Bronchiectasis: Defined by permanent dilation and destruction of bronchi due to repeated infections, bronchiectasis disrupts normal mucus clearance.
- Chronic Pneumonia: Characterized by ongoing infection and inflammation caused by various pathogens, resulting in persistent lung tissue damage (Wheeldon, 2023).
What Are the Clinical Manifestations and Diagnostic Procedures?
Patients with chronic lower respiratory infections commonly experience:
- Persistent cough with sputum production
- Wheezing and breathlessness
- Recurrent respiratory infections
- In advanced stages, weight loss, fatigue, and respiratory failure (Mandell & Read, 2010)
Diagnosis involves multiple approaches:
- Clinical history and physical exam
- Pulmonary function tests such as spirometry
- Imaging, including chest X-rays and computed tomography (CT) scans
- Microbiological analysis of sputum samples to identify causative organisms (Mahashur, 2018)
How Are Chronic Lower Respiratory Infections Treated?
Treatment aims to alleviate symptoms, slow disease progression, and improve lung function. Approaches vary by condition:
- COPD: Smoking cessation, inhaled bronchodilators, corticosteroids, pulmonary rehabilitation, and vaccinations (National Heart Lung and Blood Institute, 2023).
- Bronchiectasis: Airway clearance techniques, targeted antibiotics, and immunizations.
- Chronic Pneumonia: Pathogen-specific antibiotic therapy, supportive care, and vaccination as preventive measures (Mandell & Read, 2010).
What Feedback Was Received on the Synthesis?
Healthcare professionals reviewed the pathophysiology synthesis and described it as well-structured, clear, and informative. It effectively covered essential aspects such as etiology, clinical signs, diagnostics, and treatments. Despite positive feedback, no specific recommendations were suggested, indicating that the synthesis met its educational goals successfully. Reviewers demonstrated thorough understanding by accurately summarizing the disease characteristics, supporting the synthesis’s clarity and comprehensiveness.
Phase 1C: GoReact Video Reflection Summary
The development of the chronic lower respiratory infection synthesis was intended to provide healthcare providers with a comprehensive yet concise educational resource. Drawing from clinical experience as a Medical-Surgical Telemetry nurse, the content was carefully researched and supported with credible academic references.
One of the main challenges was condensing detailed clinical information into a single-page format without losing critical details. Peer feedback was very positive, highlighting the clear, well-organized presentation, which made complex concepts easier to understand. However, reviewers were familiar with the topic, which might have limited the scope of suggestions for improvement. Nevertheless, their ability to clearly articulate the key points reflected strong comprehension.
Phase 2.2B: Patient or Healthcare Consumer-Focused Synthesis
What Is a Stroke and What Are Its Types?
A stroke, also called a cerebrovascular accident (CVA), occurs when the blood supply to part of the brain is interrupted, either by a blockage (ischemic stroke) or a ruptured blood vessel (hemorrhagic stroke). This interruption causes brain cells to die due to lack of oxygen (American Heart Association, 2021).
What Are the Signs and Symptoms?
Symptoms depend on the affected brain region but commonly include:
- Sudden weakness or numbness on one side of the body
- Difficulty speaking or understanding speech
- Severe headache
- Loss of balance or coordination
- Visual disturbances
The mnemonic F-A-S-T (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services) aids rapid identification of stroke symptoms (National Institute of Neurological Disorders and Stroke [NINDS], n.d.).
How Is Stroke Diagnosed?
Diagnosis involves:
- Clinical examination and detailed medical history
- Imaging tests such as CT or MRI to determine stroke type and location
- Blood tests to identify risk factors and underlying causes (American Heart Association, 2021)
What Treatments Are Available?
Treatment focuses on quickly restoring blood flow and minimizing brain damage:
- Ischemic Stroke: Administration of thrombolytic agents (e.g., tissue plasminogen activator, tPA) or mechanical clot removal
- Hemorrhagic Stroke: Control of bleeding, reduction of brain pressure, and sometimes surgical intervention
- Post-acute rehabilitation including physical, occupational, and speech therapies is essential for recovery
What Preventive Measures Are Recommended?
Stroke prevention emphasizes managing risk factors through lifestyle changes such as controlling blood pressure, maintaining a healthy diet, quitting smoking, and increasing physical activity (NINDS, n.d.).
What Feedback Did Healthcare Consumers Provide?
Consumers found the stroke synthesis clear and informative, appreciating its practical guidance on recognizing symptoms and responding promptly. They suggested enhancing the document by bolding key terms to aid retention. Their ability to restate the information confirmed the effectiveness of the patient-focused synthesis in improving health literacy.
Phase 2C: GoReact Video Reflection Summary
The stroke synthesis was crafted specifically for healthcare consumers to simplify medical jargon. The primary challenge was balancing the need for brevity while maintaining accessibility for readers without medical backgrounds.
Feedback was positive, highlighting the clarity and conciseness of the material. The recommendation to highlight key terms supports better engagement and learning. This process reinforced the importance of adapting health education to the audience’s literacy level for maximum impact.
Phase 3: 3B Advanced Professional Nurse or Colleague Synthesis and Patient Treatment Plan
Case Overview: COPD Patient Ms. O’Connor
Ms. O’Connor is a 55-year-old woman experiencing worsening symptoms of COPD, including productive cough and bronchospasm. Despite efforts with nicotine replacement therapy, she continues to smoke 3 to 5 cigarettes daily. Spirometry reveals a forced expiratory volume in 1 second (FEV1) of 1.37 liters, which is 49% of the predicted value. Her family history includes smoking-related illnesses, and she has gained significant weight over two years.
What Is COPD Pathophysiology?
COPD is a chronic inflammatory disease of the lungs caused by inhaling harmful particles, resulting in airway narrowing, loss of lung elasticity, and air trapping (Agarwal et al., 2023). These structural changes lead to symptoms such as cough, shortness of breath, and sputum production.
What Are the Common Signs and Symptoms?
Typical manifestations include:
- Dyspnea (shortness of breath)
- Chronic cough and wheezing
- Excess mucus production
- Reduced exercise tolerance
- Physical signs like barrel chest, cyanosis, and clubbing of fingers (Agarwal et al., 2023)
How Is COPD Diagnosed?
Diagnosis is based on:
- Clinical history and symptom assessment
- Pulmonary function testing including spirometry
- Imaging (chest X-ray, CT scan)
- Arterial blood gas measurements
- Screening for alpha-1 antitrypsin deficiency (Agarwal et al., 2023)
What Are the Treatment Options and Potential Medication Side Effects?
| Treatment Type | Medication Examples | Purpose | Potential Side Effects |
|---|---|---|---|
| Bronchodilators | Short-acting: Albuterol | Relax airways | Tremors, tachycardia, headaches |
| Long-acting: Tiotropium | Maintain airway openness | Dry mouth, cough | |
| Inhaled Corticosteroids | Formoterol | Reduce airway inflammation | Oral thrush, hoarseness (use mouthwash) |
| Smoking Cessation | Bupropion | Support smoking cessation | Insomnia, dry mouth, tremors, seizure risk |
Non-pharmacological treatments include pulmonary rehabilitation and immunizations, which play a crucial role in disease management (Agarwal et al., 2023).
What Feedback Was Provided on the COPD Synthesis and Treatment Plan?
Colleagues praised the synthesis for its clarity, thoroughness, and easy readability. The use of bolded terms was appreciated as it enhanced retention. Engagement with the Shadow Health simulation improved clinical knowledge, assessment skills, and confidence in managing COPD. This experience highlighted the importance of effective patient education to improve health outcomes.
References
Agarwal, A. K., Raja, A., & Brown, B. D. (2023, August 7). Chronic obstructive pulmonary disease. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK559281/
American Heart Association. (2021). About stroke. American Stroke Association. https://www.stroke.org/en/about-stroke
Mahashur, A. (2018). Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India, 35(2), 143–149. https://doi.org/10.4103/lungindia.lungindia_262_17
Mandell, L. A., & Read, R. C. (2010). Infections of the lower respiratory tract. In Antibiotic and Chemotherapy (pp. 574–588). https://doi.org/10.1016/B978-0-7020-4064-1.00045-2
National Heart Lung and Blood Institute. (2023). Treatment. https://www.nhlbi.nih.gov/health/copd/treatment
National Institute of Neurological Disorders and Stroke. (n.d.). Signs and symptoms. https://www.ninds.nih.gov/health-information/stroke/signs-and-symptoms
National Institute of Neurological Disorders and Stroke. (n.d.). Assess and treat. https://www.ninds.nih.gov/health-information/stroke/assess-and-treat
National Institute of Neurological Disorders and Stroke. (n.d.). Prevention. https://www.ninds.nih.gov/health-information/stroke/prevention
U.S. National Library of Medicine. (n.d.). Albuterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a682145.html
U.S. National Library of Medicine. (n.d.). Tiotropium oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a604018.html
D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
U.S. National Library of Medicine. (n.d.-c). Formoterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a602023.html
U.S. National Library of Medicine. (n.d.). Bupropion: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a695033.html
Wheeldon, A. (2023). The respiratory system and associated disorders. British Journal of Nursing, 32(13), 613–619. https://doi.org/10.12968/bjon.2023.32.13.613
World Health Organization (WHO). (2017). Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)